Lawmakers’ yearly marijuana memo; Congressional researchers review hemp options; Record number of cannabis studies in 2022; KS cancer patient raided
Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day.
Your support makes Marijuana Moment possible…
Free to read (but not free to produce)! We’re proud of our newsletter and the reporting we publish at Marijuana Moment, and we’re happy to provide it for free. But it takes a lot of work and resources to make this happen.
If you value Marijuana Moment, invest in our success on Patreon so we can expand our coverage and more readers can benefit: https://www.patreon.com/marijuanamoment
/ TOP THINGS TO KNOW
Food and Drug Administration officials said they are taking steps to announce a plan for how to regulate cannabis-derived products like CBD and delta-8 THC in the coming months. This comes as the agency is also leading a review into marijuana’s scheduling status.
Congressional Cannabis Caucus co-chairs Reps. Earl Blumenauer (D-OR), Dave Joyce (R-OH), Barbara Lee (D-CA) and Brian Mast (R-FL) released a new memo reviewing marijuana reform accomplishments achieved this year and looking ahead at possibilities for 2023.
Read full article on Marijuana Moment
